Sign up to save your podcasts
Or
Share Advancements in Neurodegenerative Disease Therapies and Ecommerce Scalability
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Advancements in Neurodegenerative Disease Therapies and Ecommerce Scalability
Annovis Bio Inc. has been granted an 18-month compliance plan by the NYSE to continue trading while focusing on developing therapies for neurodegenerative diseases. Meanwhile, ScaleOps, led by Andrew Ukpabi, is revolutionizing ecommerce scalability by providing predictable growth and exit potential for brands through innovative strategies.
View all episodes
By NewsRampAnnovis Bio Inc. has been granted an 18-month compliance plan by the NYSE to continue trading while focusing on developing therapies for neurodegenerative diseases. Meanwhile, ScaleOps, led by Andrew Ukpabi, is revolutionizing ecommerce scalability by providing predictable growth and exit potential for brands through innovative strategies.